Dr. Brian Bressler
Gastroenterologist · Ulcerative Colitis · Crohn's Disease · Vancouver, British Columbia
Dr. Brian Bressler is a Clinical Assistant Professor of Medicine in the Division of Gastroenterology at the University of British Columbia Department of Medicine. Having received his MD from the University of British Columbia, Dr. Bressler completed his residency at the Internal Medicine and Gastroenterology at the University of Toronto, after which he received an MS in Epidemiology from the Harvard Public School of Health and an Advanced Fellowship in Inflammatory Bowel Disease at Massachusetts General Hospital, Harvard Medical School.
Following his advanced training at Harvard Medical School, Dr. Bressler has continued to treat patients, educate students and shares his insights with fellow gastroenterologists at patient education events. He is also a member of the GI Research Institute in Vancouver, one of the most active gastroenterology research centers in North America.
"Participating in a clinical trial can offer you an opportunity that really can be better than anything else you have available. "
-Dr. Brian Bressler
Our mission is to transform patients’ access to new treatment options to improve their health and accelerate research to find cures.
The search for new treatments and cures progresses at a glacial pace, starving many patients of the opportunity to have better treatments and cures in their lifetime. We are changing this by connecting patients with the cutting-edge treatments options that are available to them through research. By making this connection simple for patients and simple for researchers, we will find cures faster.
Our passion for empowering patients, our decades of experience in clinical research and our expertise with technology are enabling us to break down the barriers in research. With a community of over 30,000 patients and researchers rallying with us, we are not the only ones excited about our mission.
Clinical Associate Professor of Medicine, Division of Gastroenterology
The Gastrointestinal (GI) Clinic at St. Paul’s provides endoscopic procedures on an outpatient, inpatient, and emergency basis. It is supported by gastroenterology and colorectal surgery. The clinic performs over 9,000 standard and specialized procedures each year.
Qu Biologics was founded in 2007 by physician Dr. Hal Gunn and businessman and cancer survivor Rob Freeman. The company’s vision began with a desire to develop treatments that re-establish health by restoring the body’s normal immune function and innate capacity to heal. This vision continues to guide us today. Qu Biologics’ Site Specific Immunomodulators (SSIs) are designed to stimulate activated innate immune cell recruitment to the targeted organ or tissue to restore immune function and treat a range of chronic diseases, including cancer and inflammatory bowel disease.